The Rising Influence of Mindfulness-Based Cognitive Therapy in Depression Treatment
International Journal of Social Science and Human Research November 17, 2023 DOI: 10.47191/ijsshr/v6-i11-29 (opens in new tab)
Summary
AI-generated from the abstractMindfulness-based cognitive therapy (MBCT) reduces current symptoms of depression and lowers the risk of relapse to a similar extent as maintenance antidepressants. Neuroimaging studies show functional brain changes that correlate with clinical improvements after MBCT. Delivery methods are expanding to include online platforms and applications, while traditional in-person settings are being optimized. Limitations include issues with patient diversity, teaching quality, cost-effectiveness, and accessibility. Further research on implementation is needed to broaden MBCT's scope and enhance its effectiveness in different care settings.
Study at a glance
| Characteristics | Review Randomized Peer reviewed |
|---|---|
| Intervention | Mindfulness-based cognitive therapy |
| Key finding | MBCT reduces current symptoms of depression and lowers the risk of relapse to a similar extent as maintenance antidepressants. |
Abstract
Major depressive disorder is a common and recurring condition that necessitates ongoing advancements in treatment. The integration of mindfulness meditation and cognitive behavioural techniques in mindfulness-based cognitive therapy (MBCT) has shown promise as an effective approach. This review focuses on the current evidence regarding MBCT's efficacy in treating acute depression and preventing relapse. A comprehensive search was conducted across various databases to identify randomized controlled trials, systematic reviews, and meta-analyses from the last decade that evaluate MBCT. The results consistently indicate that MBCT is able to reduce current symptoms of depression and lower the risk of relapse to a similar extent as maintenance antidepressants. Additionally, neuroimaging studies have revealed functional changes in the brain that correlate with clinical improvements following MBCT. There is a growing trend towards expanding the delivery methods for MBCT, including online platforms and applications, while also optimizing traditional in-person settings. However, there are several limitations that need to be addressed. These include issues surrounding patient diversity, teaching quality, cost-effectiveness, and accessibility. To broaden the scope of MBCT and enhance its effectiveness in different care settings, further research on implementation is necessary. To summarize, MBCT has demonstrated consistent efficacy in treating major depression, but there is a need to continuously improve its accessibility and delivery methods as it becomes more widely available